The American College of Cardiology has canceled ACC.20/WCC in Chicago, scheduled to take place March 28 through 30. The ACC made the decision in reaction to the COVID-19 outbreak; “we believe it is in the best interest of everyone to cancel the meeting and ensure our members are able to do what they do best – help and heal,” the group said.
Menlo Park, Calif.-based Avellino Labs USA Inc. said that its newly developed coronavirus diagnostic test has been validated, pending the U.S. FDA’s independent review. The test uses the company’s existing genetic diagnostics platform to help clinicians diagnose COVID-19.
Hoffman Estates, Ill-based Clinical Computer Systems Inc., which focuses on perinatal systems software, reported a reseller agreement with Alertwatch, an Ann Arbor, Mich.-based provider of real-time clinical decision support software. Under this reseller agreement, the former will distribute, within the U.S., Alertwatch:OB's FDA 510(k)-cleared Maternal Safety System.
Cybermdx, a New York-based health care cybersecurity provider, and Sham, part of the Relyens group, of Lyon, France, Europe's largest insurance and risk management provider for health care, reported a partnership that will introduce the former’s visibility and cybersecurity capabilities to Sham's offering to create a first-of-its-kind, end-to-end risk management solution for health care.
Daxor Corp., of New York, said the U.S. Air Force (USAF) has awarded it a contract to define specifications to adapt blood volume analysis technology to meet the needs of USAF.
Vista, Calif.-based Exagen Inc. said that three California medical groups will offer Avise testing as a covered in-network benefit for their patients. Avise tests are used to diagnose complex autoimmune and autoimmune-related diseases, such as rheumatoid arthritis and lupus.
Eyedaptic Inc., a natural vision software company based in Laguna Beach, Calif., reported a partnership with Vispero, an assistive technology provider for the visually impaired that has a presence in Clearwater, Fla., to expand its reach of visually assistive augmented reality devices. By partnering together, Eyedaptic and Vispero can offer broader access of their low vision solution to the community.
A diagnostic test for COVID-19 from Hologic Inc., of Marlborough, Mass., designed for use in a diagnostic system that can process up to 1,000 tests in 24 hours, will receive advanced development support from the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. The Biomedical Advanced Research and Development Authority will contribute $699,000 to accelerate Hologic's development of a test that detects the genetic material of SARS-CoV-2, the virus that causes COVID-19. Test results could be available to clinicians in less than three hours.
Htc Vive, of New Taipei City, Taiwan, and Alameda, Calif.-based Penumbra Inc. reported that Penumbra’s Real Immersive system for stroke recovery utilizes a custom-designed Vive Focus virtual reality headset. The Real Immersive System is a portable VR tool for upper-body rehabilitation that can be used at the patient’s bedside, in gym or other location.
Invacare Corp., of Elyria, Ohio, reported that it has completed the sale of its Dynamic Controls subsidiary to Allied Motion Technologies Inc., of Amherst, N.Y. Financial terms of the transaction were not disclosed.
Boston-based Invicro LLC, a Konica Minolta company, is collaborating with David Rimm, of the Yale University School of Medicine, to advance Konica Minolta’s nanoparticle-based detection technology, Quanticell, for clinical pathology applications. Under the agreement, Rimm and his team will evaluate numerous assay conditions to assess Quanticell’s performance in quantifying HER-2 expression across a wide dynamic range.
Lhc Group Inc., of Lafayette, La., has established an internal multidisciplinary COVID-19 task force to coordinate resources and efforts to address the virus. As part of that effort, the company has begun prescreening and protection protocols for all its 32,000 employees and is working to ensure its workforce has adequate protective equipment and supplies.
Medicortex Finland Oy, of Turku, Finland, has launched a clinical trial its ProbTBI for the detection of mild traumatic brain injury in children. The rapid diagnostic kit is designed to diagnose brain injury especially in patients without visible signs of brain damage, such as often occurs with concussion.
New York-based Northwell Labs, part of the Northwell Health enterprise, said it has received state and federal authorization to begin manual testing for COVID-19. The company expects to test 90 potential samples of the novel coronavirus within the first full day.
Nyxoah SA, of Mont-Saint-Guibert, Belgium, reported the successful first two implantations of its Genio obstructive sleep apnea solution in Belgium. The procedures were performed at the Antwerp University Hospital.
Pavmed Inc., of New York, said the U.S. FDA has acknowledged receipt of its 510(k) resubmission for the Carpx minimally invasive carpal tunnel device. The resubmission includes data from the company’s first-in-human Carpx clinical safety trial, in which all patients met prespecified safety and effectiveness endpoints.
Houston-based Soliton Inc. has inked an agreement with Sanmina Corp., of San Jose, Calif., to manufacture Soliton’s Rapid Acoustic Pulse device and replaceable cartridges. The FDA-cleared device for tattoo removal is expected to launch in the middle of this year.
San Mateo, Calif.-based Ulab Systems, which created an aligner system that it says gives control back to orthodontists, reported that it has doubled its sales team to support continued growth.